PBX4 and cancer: The results showed that PBX4 expression was significantly associated with survival prognosis, molecular and immune subtypes, mutation status, DNA methylation, immune infiltration, and therapy responses in various human cancers, which contributed to understanding the potential roles of PBX4 in various human cancers from several different perspectives.